top of page

Cipla Ltd

  • Writer: Sunanda Majumder
    Sunanda Majumder
  • Dec 11, 2024
  • 1 min read

Updated: Aug 12, 2025


Cipla Ltd is an 89-year-old pharma company managed by Mr. Umang Vohra (MD & CEO), Dr. Y. K. Hamied (Non-Executive Chairman) and employs more than 22,000 people. Spread in 14 countries, their products are vaccines, diagnostics, pharmaceutical drugs, dietary supplements, protein supplements, generic drugs, contact lances, etc. Although the pharma and healthcare sectors are very close. Cipla launched its IPO in 2002 at Rs 74.80 and has shown nearly 225.12% growth in the last 5 years. However, their revenue is 26,521 crore and net profit is 4,155 crore for FY 2023-24.

Comments


Subscribe for latest updates • Don’t miss out!

Our Details

© 2035 by Unsold 70

Build a future-ready portfolio with Unsold70

Here is a Gateway of becoming a smart and informed stock market investor. At Unsold70, we bring you powerful stock market basics and a selected list of best 70 companies that are worth investing in. No matter you are a beginner or an experienced investor, our research-driven stock market news helps you uncover undervalued stocks with high growth potential.

 

Our team analyzes the trends, financials, and market movements to provide clear, actionable advice for confident investing. If you have the question how to invest in stock market in your mind, stay ahead with our expert updates, performance tracking, and real-time stock signals.

 

We refine our top 70 list regularly as per the recent stock market changes. Hence, we try to help the investors building a strong, stable, and future-ready portfolio. The right picks today can shape your financial success tomorrow. Explore smarter ways to invest and grow your wealth.

bottom of page